CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cardiex Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cardiex Ltd
Suite 301, 15 Lime St.
Phone: +61 298748761p:+61 298748761 SYDNEY, NSW  NSW 2000  Australia Ticker: CDXCDX

Business Summary
CardieX Limited is an Australia-based health technology company. It is engaged in designing, manufacturing, and marketing medical devices for use in cardiovascular health management, and the development of clinical and consumer digital health solutions. It is focused on hypertension, cardiovascular disease, and other vascular health disorders. It operates through its subsidiaries, including ATCOR and CONNEQT. ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its SphygmoCor technology. Under the ATCOR.X brand, it also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. Its digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients’ health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness parameters.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20236/30/2023YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board NiallCairns 8/6/2019 12/20/2017
Chief Executive Officer, Executive Director CraigCooper 12/1/2017 12/1/2017
Vice President - Operations SteveBraaten 1/31/2023 1/31/2023
4 additional Officers and Directors records available in full report.

Business Names
Business Name
ACG
AtCor Medical Holdings Limited
Blumio, Inc.
CDX
CDXDA

General Information
Number of Employees: 26 (As of 6/30/2012)
Outstanding Shares: 143,683,524 (As of 12/31/2023)
Shareholders: 2,381
Stock Exchange: ASX


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, March 27, 2024